نتایج جستجو برای: mrd

تعداد نتایج: 1567  

Journal: :Blood 2005
Barbara Wassmann Heike Pfeifer Michael Stadler Martin Bornhaüser Gesine Bug Urban J Scheuring Patrick Brück Matthias Stelljes Rainer Schwerdtfeger Nadezda Basara Jolanta Perz Donald Bunjes Georg Ledderose Rolf Mahlberg Anja Binckebanck Harald Gschaidmeier Dieter Hoelzer Oliver G Ottmann

In adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), minimal residual disease (MRD) after stem cell transplantation (SCT) is associated with a relapse probability exceeding 90%. Starting imatinib in the setting of MRD may decrease this high relapse rate. In this prospective multicenter study, 27 Ph+ ALL patients received imatinib upon detection of MRD after SCT. Bcr...

2016
Wanmao Ni Beili Hu Cuiping Zheng Yin Tong Lei Wang Qing-qing Li Xiangmin Tong Yong Han

We investigated the ability of support vector machines (SVM) to analyze minimal residual disease (MRD) in flow cytometry data from patients with acute myeloid leukemia (AML) automatically, objectively and standardly. The initial disease data and MRD review data in the form of 159 flow cytometry standard 3.0 files from 36 CD7-positive AML patients in whom MRD was detected more than once were exp...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Sara Galimberti Stefano Luminari Elena Ciabatti Susanna Grassi Francesca Guerrini Alessandra Dondi Luigi Marcheselli Marco Ladetto Pier Paolo Piccaluga Anna Gazzola Claudia Mannu Luigia Monitillo Barbara Mantoan Ilaria Del Giudice Irene Della Starza Marzia Cavalli Luca Arcaini Alessandra Tucci Giuseppe Alberto Palumbo Luigi Rigacci Alessandro Pulsoni Umberto Vitolo Carola Boccomini Daniele Vallisa Giovanni Bertoldero Gianluca Gaidano Pellegrino Musto Mario Petrini Massimo Federico

PURPOSE The role of the minimal residual disease (MRD) in follicular lymphoma is still debated. In this study, we assessed whether the BCL2/IGH rearrangement could have a prognostic role in patients receiving R-CHOP, R-FM, or R-CVP. EXPERIMENTAL DESIGN DNAs from 415 patients among the 504 cases enrolled in the FOLL05 trial (NCT00774826) were centralized and assessed for the BCL2/IGH at diagno...

Journal: :Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2013
Zhiye Chen Jinfeng Li Mengyu Liu Lin Ma

OBJECTIVE To investigate the age-related changes in resting functional connectivity of the marginal division (MrD) of the neostriatum in healthy adults detected using resting-state functional magnetic resonance imaging (rs-fMRI). METHODS Forty-four healthy volunteers aged between 22 and 44 years (mean 30.36∓6.31 years) and 20 elderly volunteers aged between 48-83 years (mean 61.4∓10.25 years)...

2014
Elias Hallack Atta Danielli Cristina Muniz de Oliveira Luis Fernando Bouzas Márcio Nucci Eliana Abdelhay

One of the major drawbacks for unrelated donor (UD) bone marrow transplantation (BMT) is graft-versus-host disease (GVHD). Despite results from randomized trials, antithymocyte globulin (ATG) is not routinely included for GVHD prophylaxis in UD BMT by many centers. One of ways to demonstrate the usefulness of rabbit ATG in UD BMT is to evaluate how its results approximate to those observed in m...

2017
H M Eissa Y Zhou J C Panetta E K Browne S Jeha C Cheng M V Relling D Campana C-H Pui H Inaba

The impact of body mass index (BMI) at diagnosis on treatment outcome in children with acute lymphoblastic leukemia (ALL) is controversial. We studied 373 children with ALL enrolled on the Total XV study, which prospectively used minimal residual disease (MRD) for risk assignment. MRD on day 19 and at the end of remission induction (day 46), cumulative incidence of relapse/refractory disease (C...

2012
Axel Weber Sylvia Taube Udo zur Stadt Martin Horstmann Knut Krohn Jutta Bradtke Andrea Teigler-Schlegel Sabine Leiblein Holger Christiansen

The amplification of putative oncogenes is a common finding within the genome of various cancer types. Identification and further targeting of specific junction sites within the sequence of genomic amplicons (amplicon fusion sites, AFS) by PCR (AFS-PCR) is suitable for quantification of minimal residual disease (MRD). This approach has recently been developed and described for MYCN amplified ne...

2015
Sima Ajami Saedeh Ketabi Fatemeh Torabiyan

UNLABELLED Medical Record Department (MRD) has a vital role in making short and long term plans to improve health system services. The aim of this study was to describe performance improvement indicators of hospital MRD and information technology (IT). COLLECTION OF DATA A search was conducted in various databases, through related keywords in articles, books, and abstracts of conferences from...

Journal: :Blood 2012
Max S Topp Nicola Gökbuget Gerhard Zugmaier Evelyn Degenhard Marie-Elisabeth Goebeler Matthias Klinger Svenja A Neumann Heinz A Horst Thorsten Raff Andreas Viardot Matthias Stelljes Markus Schaich Rudolf Köhne-Volland Monika Brüggemann Oliver G Ottmann Thomas Burmeister Patrick A Baeuerle Dirk Nagorsen Margit Schmidt Hermann Einsele Gert Riethmüller Michael Kneba Dieter Hoelzer Peter Kufer Ralf C Bargou

Persistence or recurrence of minimal residual disease (MRD) after chemotherapy results in clinical relapse in patients with acute lymphoblastic leukemia (ALL). In a phase 2 trial of B-lineage ALL patients with persistent or relapsed MRD, a T cell-engaging bispecific Ab construct induced an 80% MRD response rate. In the present study, we show that after a median follow-up of 33 months, the hemat...

2005
Barbara Wassmann Heike Pfeifer Michael Stadler Martin Bornhäuser Gesine Bug Urban J. Scheuring Patrick Brück Matthias Stelljes Rainer Schwerdtfeger Nadezda Basara Jolanta Perz Donald Bunjes Georg Ledderose Rolf Mahlberg Anja Binckebanck Harald Gschaidmeier Dieter Hoelzer Oliver G. Ottmann

In adult Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph ALL), minimal residual disease (MRD) after stem cell transplantation (SCT) is associated with a relapse probability exceeding 90%. Starting imatinib in the setting of MRD may decrease this high relapse rate. In this prospective multicenter study, 27 Ph ALL patients received imatinib upon detection of MRD after SCT. Bcr-a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید